Jin Medical International Ltd.
ZJYL
$0.6407
-$0.0019-0.30%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.57% | 9.62% | 0.74% | 1.99% | 3.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.57% | 9.62% | 0.74% | 1.99% | 3.29% |
| Cost of Revenue | 8.06% | 3.20% | -1.53% | -0.68% | 0.19% |
| Gross Profit | 37.98% | 21.80% | 5.17% | 7.29% | 9.55% |
| SG&A Expenses | 83.89% | 68.58% | 51.11% | 29.66% | 9.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -40.44% | -31.93% | -23.52% | -6.56% | 12.78% |
| Total Operating Expenses | 17.16% | 10.63% | 4.15% | 1.77% | -0.62% |
| Operating Income | 26.91% | 3.67% | -19.42% | 3.51% | 34.57% |
| Income Before Tax | 29.85% | 11.86% | -5.00% | 4.98% | 17.48% |
| Income Tax Expenses | 122.29% | 127.30% | 136.35% | 250.53% | 849.17% |
| Earnings from Continuing Operations | 18.82% | 1.81% | -13.27% | -4.35% | 6.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.71% | 7.45% | -10.51% | -2.85% | 6.35% |
| EBIT | 26.91% | 3.67% | -19.42% | 3.51% | 34.57% |
| EBITDA | 25.32% | 1.95% | -20.53% | -1.05% | 24.08% |
| EPS Basic | 15.84% | -4.98% | -22.50% | -11.82% | 1.00% |
| Normalized Basic EPS | 29.58% | 5.26% | -15.00% | -3.47% | 10.94% |
| EPS Diluted | 15.84% | -4.98% | -22.50% | -11.82% | 1.00% |
| Normalized Diluted EPS | 29.58% | 5.26% | -15.00% | -3.47% | 10.94% |
| Average Basic Shares Outstanding | 7.81% | 11.40% | 15.26% | 11.39% | 7.51% |
| Average Diluted Shares Outstanding | 7.81% | 11.40% | 15.26% | 11.39% | 7.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |